Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of clinical anesthesia

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JCLINANE.2005.08.018PMID 16563327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuously assessed right ventricular end-diastolic volume as a marker of cardiac preload and fluid responsiveness in mechanically ventilated cardiac surgical patients

  2005cited by this paper
• Inhalative Vasodilatatoren in der kardiochirurgischen Intensivmedizin

  2005cited by this paper
• First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.

  2003cited by this paper
• Sablotzki, A. et al. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Can. J. Anaesth. 49, 1076-1080

  2002cited by this paper
• Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension

  2002cited by this paper
• Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.

  2001influential reference
• Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue.

  2001cited by this paper
• Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution

  2000influential reference
• A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.

  2000cited by this paper
• Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

  1998cited by this paper
• Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes.

  1997cited by this paper
• Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes.

  1997cited by this paper
• Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

  1996cited by this paper
• Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide.

  1995cited by this paper
• Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure.

  1994cited by this paper
• Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

  1994cited by this paper
• Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity.

  1993cited by this paper
• Safety guidelines for use of nitric oxide.

  1992cited by this paper
• Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilatation in Pulmonary Hypertension

  1991cited by this paper
• Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents.

  1991cited by this paper
• Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.

  1990cited by this paper
• Pulmonary vascular resistance and the risk of heart transplantation.

  1988cited by this paper

• Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction—the ILO‐HOPE randomised controlled trial

  2020cites this paper
• Inhaled Prostacyclin on Exercise Echocardiographic Cardiac Function in Preserved Ejection Fraction Heart Failure.

  2020cites this paper
• О возможности повышения информативности диагностики необратимой легочной гипертензии у кандидатов на трансплантацию сердца

  2019cites this paper
• On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates

  2019cites this paper
• Влияние снижения тонуса сосудов различных регионов на показатели центральной гемодинамики пациентов с выраженной систолической дисфункцией левого желудочка

  2018cites this paper
• Pulmonary Hypertension in the Era of Mechanical Circulatory Support

  2016cites this paper
• Comparison of continuous-flow and pulsatile-flow blood pumps on reducing pulmonary artery pressure in patients with fixed pulmonary hypertension.

  2013cites this paper
• Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates.

  2013cites this paper
• Anästhesie in der Chirurgie des Herzens und der herznahen Gefäße

  2012cites this paper
• Iloprost—different indications and different national experiences in treating pulmonary hypertension

  2010cites this paper
• Plicní hypertenze u chronického srdečního selhání a možnosti jejího ovlivnění

  2009cites this paper
• Inhalative iloprost – pharmacology and clinical application

  2009cites this paper
• Inhalativeiloprost-pharmacology andclinicalapplication

  2009cites this paper
• Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.

  2008cites this paper
• Iloprost in pulmonary hypertension

  2008cites this paper
• In vivo animal models for drug delivery across the lung mucosal barrier.

  2007cites this paper
• EFFECTS OF INHALED AEROSOLIZED ILOPROST AND INHALED NO ON PULMONARY CIRCULATION AND EDEMA FORMATION IN OVINE LUNG INJURY

  2007cites this paper